“…C-Glycosyl 1,2,4-triazoles are an even more uncommon type [15][16][17][18] and only in recent years has progress been made in this field with the syntheses of 3-glycopyranosyl-5-substituted-1,2,4-triazoles as glycogen phosphorylase inhibitors for potential antidiabetic use. [19][20][21][22][23][24] As a continuation of our efforts in the above syntheses, the preparation of trisubstituted Cglycopyranosyl 1,2,4-triazoles was envisaged to generate molecules for structure-activity relationships of glycogen phosphorylase inhibitors and also for other potential biological applications. From the three possible isomeric structures (Scheme 1) some examples of the 3-glycosyl-4,5-disubstituted-1,2,4-triazoles (I) were already described, 21 therefore, this work has focused on the 3-β-D-glucopyranosyl-1,5-disubstituted (II) and 5-β-D-glucopyranosyl-1,3-disubstituted (III) counterparts.…”